https://scholars.lib.ntu.edu.tw/handle/123456789/639896
標題: | Cetuximab Treatment beyond Progression in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: A Nationwide Population-Based Study (THNS-2021-08) | 作者: | Wang, Hung-Ming PEI-JEN LOU Yang, Muh-Hwa Chen, Tein-Hua Lien, Ming-Yu Lin, Jin-Ching JO-PAI CHEN Lu, Wei-Chen Lu, Hsueh-Ju Huang, Tai-Lin Yen, Chia-Jui Wu, Shang-Yin Wang, Hui-Ching Hsieh, Meng-Che |
公開日期: | 一月-2024 | 卷: | 19 | 期: | 1 | 來源出版物: | Targeted oncology | 摘要: | Little is known regarding the association of cetuximab treatment beyond progression (TBP) with survival among patients with recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC). Although immune checkpoint inhibitors (ICIs) are now considered as first-line treatment, not all patients are suitable for ICIs. |
URI: | https://scholars.lib.ntu.edu.tw/handle/123456789/639896 | ISSN: | 17762596 | DOI: | 10.1007/s11523-023-01028-7 |
顯示於: | 醫學院附設醫院 (臺大醫院) |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。